| scholarly article | Q13442814 |
| P2093 | author name string | A Oka | |
| P A Rosenberg | |||
| J J Volpe | |||
| M J Belliveau | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacology | Q128406 |
| oligodendrocyte | Q916698 | ||
| prevention | Q1717246 | ||
| P304 | page(s) | 1441-1453 | |
| P577 | publication date | 1993-04-01 | |
| P1433 | published in | Journal of Neuroscience | Q1709864 |
| P1476 | title | Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention | |
| P478 | volume | 13 |
| Q37385634 | 12/15-lipoxygenase expression is increased in oligodendrocytes and microglia of periventricular leukomalacia |
| Q48319077 | 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline reduces glial loss and acute white matter pathology after experimental spinal cord contusion |
| Q94461671 | 4-Hydroxyestrone, an Endogenous Estrogen Metabolite, Can Strongly Protect Neuronal Cells Against Oxidative Damage |
| Q33866856 | A light and electron microscopic study of NG2 chondroitin sulfate proteoglycan-positive oligodendrocyte precursor cells in the normal and kainate-lesioned rat hippocampus |
| Q48949775 | A light- and electron-microscopic study of GluR4-positive cells in cerebral cortex, subcortical white matter and corpus callosum of neonatal, immature and adult rats. |
| Q50516298 | A new Alamar Blue viability assay to rapidly quantify oligodendrocyte death. |
| Q44511847 | ACTH protects mature oligodendroglia from excitotoxic and inflammation-related damage in vitro |
| Q43823406 | AMPA-Induced suppression of oligodendroglial gene expression in neonatal rat brain. |
| Q47241393 | Acid sphingomyelinase promotes mitochondrial dysfunction due to glutamate-induced regulated necrosis |
| Q40631378 | Activation of stimulatory heterotrimeric G proteins increases glutathione and protects neuronal cells against oxidative stress |
| Q33730910 | Activity of D-amino acid oxidase is widespread in the human central nervous system |
| Q43638894 | Ampa/kainate receptor activation mediates hypoxic oligodendrocyte death and axonal injury in cerebral white matter. |
| Q35134958 | Animal models of periventricular leukomalacia |
| Q47565480 | Antenatal and Neonatal Antecedents of Executive Dysfunctions in Extremely Preterm Children |
| Q48373812 | Antenatal glucocorticoid, magnesium exposure, and the prevention of brain injury of prematurity |
| Q36239170 | Antioxidants and polyunsaturated fatty acids in multiple sclerosis |
| Q36492301 | Antioxidants in multiple sclerosis: do they have a role in therapy? |
| Q44050860 | Apoptosis of oligodendrocytes in secondary cultures from neonatal rat brains |
| Q36104665 | Astrocytic contributions to bioenergetics of cerebral ischemia |
| Q39384950 | Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted gliomas |
| Q83381161 | Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted gliomas |
| Q33884684 | Brain damage in preterm newborns: biological response modification as a strategy to reduce disabilities |
| Q41688313 | Brain injury in the premature infant--from pathogenesis to prevention |
| Q48373846 | Brain injury in the premature infant: overview of clinical aspects, neuropathology, and pathogenesis |
| Q33623734 | CXCR2 signaling protects oligodendrocytes and restricts demyelination in a mouse model of viral-induced demyelination |
| Q35144325 | Calcium-permeable AMPA/kainate receptors mediate toxicity and preconditioning by oxygen-glucose deprivation in oligodendrocyte precursors |
| Q38222889 | Cannabinoids: well-suited candidates for the treatment of perinatal brain injury. |
| Q44499286 | Caspase inhibition attenuates transection-induced oligodendrocyte apoptosis in the developing chick spinal cord |
| Q41030810 | Cellular mechanisms of resistance to chronic oxidative stress |
| Q79209797 | Cerebral palsy |
| Q53602011 | Complex interplay between glutamate receptors and intracellular Ca2+ stores during ischaemia in rat spinal cord white matter. |
| Q34312137 | Could cord blood cell therapy reduce preterm brain injury? |
| Q34449733 | Critical role of the JNK-p53-GADD45α apoptotic cascade in mediating oxidative cytotoxicity in hippocampal neurons |
| Q24814378 | Cu/Zn superoxide dismutase expression in the postnatal rat brain following an excitotoxic injury |
| Q79453321 | Cyclic GMP-dependent pathways protect differentiated oligodendrocytes from multiple types of injury |
| Q48703799 | Cystine/glutamate antiporter blockage induces myelin degeneration. |
| Q48283279 | Demyelination: the role of reactive oxygen and nitrogen species |
| Q46632836 | Dopamine D2 and D3 receptor agonists limit oligodendrocyte injury caused by glutamate oxidative stress and oxygen/glucose deprivation |
| Q33709233 | Drug development for stroke: importance of protecting cerebral white matter |
| Q48794249 | Effects of glutamate receptor agonists and antagonists on Ca2+ uptake in rat hippocampal slices lesioned by glucose deprivation or by kainate. |
| Q64105729 | Electrical stimulation enhances neuronal cell activity mediated by Schwann cell derived exosomes |
| Q37396967 | Erythropoietin signaling promotes oligodendrocyte development following prenatal systemic hypoxic-ischemic brain injury |
| Q36822954 | Excitotoxic damage to white matter. |
| Q46488778 | Excitotoxic oligodendrocyte death and axonal damage induced by glutamate transporter inhibition |
| Q46836673 | Excitotoxicity and mitochondrial dysfunction underlie age-dependent ischemic white matter injury |
| Q34768751 | Excitotoxicity in glial cells. |
| Q36283207 | Excitotoxins, Mitochondrial and Redox Disturbances in Multiple Sclerosis |
| Q37691262 | Experimental models for analysis of oligodendrocyte pathophysiology in stroke |
| Q92023336 | Ferroptosis and Brain Injury |
| Q42688849 | Fetal carotid blood flow during videofetoscopy |
| Q57464776 | Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration |
| Q52606339 | Fibrinogen in neurological diseases: mechanisms, imaging and therapeutics. |
| Q31967393 | Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms |
| Q45904559 | Functional glutamate transport in rodent optic nerve axons and glia. |
| Q37312220 | General control nonderepressible 2 (GCN2) kinase protects oligodendrocytes and white matter during branched-chain amino acid deficiency in mice |
| Q64094057 | Glutamate Transport and Preterm Brain Injury |
| Q38750023 | Glutamate and ATP at the Interface Between Signaling and Metabolism in Astroglia: Examples from Pathology |
| Q37824652 | Glutamate and the biology of gliomas |
| Q41612066 | Glutamate receptors on myelinated spinal cord axons: II. AMPA and GluR5 receptors |
| Q48617168 | Glutamate transporter protein subtypes are expressed differentially during rat CNS development. |
| Q28190140 | Glutamate uptake |
| Q40717306 | Glutamate-induced c-Src activation in neuronal cells |
| Q46931709 | Glutamate-induced cell death and formation of radicals can be reduced by lisuride in mesencephalic primary cell culture |
| Q36277315 | Glutamate-mediated glial injury: mechanisms and clinical importance |
| Q31032734 | Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder |
| Q44770096 | Glutathione peroxidase-catalase cooperativity is required for resistance to hydrogen peroxide by mature rat oligodendrocytes. |
| Q35040297 | Hemorrhagic-ischemic cerebral injury in the preterm infant: current concepts |
| Q41763185 | Histone deacetylase inhibitors preserve white matter structure and function during ischemia by conserving ATP and reducing excitotoxicity |
| Q52183184 | Human oligodendroglial development: relationship to periventricular leukomalacia. |
| Q35009330 | Hyperoxia causes maturation-dependent cell death in the developing white matter. |
| Q48507847 | Hypoxia-ischemia preferentially triggers glutamate depletion from oligodendroglia and axons in perinatal cerebral white matter. |
| Q41501753 | Hypoxic and ischemic disorders of infants and children. Lecture for 38th meeting of Japanese Society of Child Neurology, Tokyo, Japan, July 1996. |
| Q40480511 | Hypoxic-ischemic encephalopathy. Therapeutic approaches against microvascular injury, and role of neutrophils, PAF, and free radicals. |
| Q84032448 | Idebenone inhibition of glutamate release from rat cerebral cortex nerve endings by suppression of voltage-dependent calcium influx and protein kinase A |
| Q28771339 | Identification of Bax-interacting proteins in oligodendrocyte progenitors during glutamate excitotoxicity and perinatal hypoxia-ischemia |
| Q45242550 | Identification of neuroprotective properties of anti-MAG antibody: a novel approach for the treatment of stroke? |
| Q35006336 | Importance of astrocytic inactivation of synaptically released glutamate for cell survival in the central nervous system--are astrocytes vulnerable to low intracellular glutamate concentrations? |
| Q89442038 | Improvement by Human Oligodendrocyte Progenitor Cells of Neurobehavioral Disorders in an Experimental Model of Neonatal Periventricular Leukomalacia |
| Q36896275 | Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury |
| Q38954648 | Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders |
| Q28370578 | Inhibition of L-homocysteic acid and buthionine sulphoximine-mediated neurotoxicity in rat embryonic neuronal cultures with alpha-lipoic acid enantiomers |
| Q37189377 | Inhibition of cystine uptake disrupts the growth of primary brain tumors |
| Q36437643 | Interferon-gamma-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. |
| Q48395954 | Intracellular calcium and cell death during ischemia in neonatal rat white matter astrocytes in situ. |
| Q57143170 | Kir4.1 channels in NG2-glia play a role in development, potassium signaling, and ischemia-related myelin loss |
| Q52151873 | Lipopolysaccharide-Induced Apoptosis of Astrocytes: Therapeutic Intervention by Minocycline. |
| Q43562348 | MK-801 is cytotoxic to microglia in vitro and its cytotoxicity is attenuated by glutamate, other excitotoxic agents and atropine. Possible presence of glutamate receptor and muscarinic receptor on microglia |
| Q36703103 | Magnetic resonance imaging in perinatal asphyxia |
| Q37165162 | Maturation-dependent sensitivity of oligodendrocyte lineage cells to apoptosis: implications for normal development and disease |
| Q34121946 | Mechanism for the protective effect of resveratrol against oxidative stress-induced neuronal death |
| Q42362870 | Microbiome profile of the amniotic fluid as a predictive biomarker of perinatal outcome |
| Q30479718 | Molecular basis of vitamin E action: tocotrienol modulates 12-lipoxygenase, a key mediator of glutamate-induced neurodegeneration |
| Q37625399 | Molecular features of neural stem cells enable their enrichment using pharmacological inhibitors of survival-promoting kinases |
| Q37405402 | Myelin abnormalities without oligodendrocyte loss in periventricular leukomalacia |
| Q34169938 | Myelin transcription factor 1 (MyT1) immunoreactivity in infants with periventricular leukomalacia |
| Q35642650 | N-acetyl-L-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro |
| Q46865596 | N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder |
| Q36537754 | N-methyl-D-aspartate receptor-mediated axonal injury in adult rat corpus callosum |
| Q73315790 | NBQX attenuates excitotoxic injury in developing white matter |
| Q73258586 | NMDA and glutamate evoke excitotoxicity at distinct cellular locations in rat cortical neurons in vitro |
| Q41843868 | NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. |
| Q37755972 | Neurobiology of injury to the developing brain |
| Q40942772 | Neuroprotective effects of alpha-lipoic acid and its positively charged amide analogue |
| Q24671657 | Neurotransmitter receptors in the life and death of oligodendrocytes |
| Q38102686 | Neurotransmitter signaling in the pathophysiology of microglia |
| Q34844716 | Neurotransmitter-triggered transfer of exosomes mediates oligodendrocyte-neuron communication |
| Q95270886 | Novel Treatment Strategies Targeting Myelin and Oligodendrocyte Dysfunction in Schizophrenia |
| Q33966953 | Novel role of vitamin k in preventing oxidative injury to developing oligodendrocytes and neurons. |
| Q38076363 | Oligodendrocyte N-methyl-D-aspartate receptor signaling: insights into its functions |
| Q38202292 | Oligodendrocyte pathophysiology and treatment strategies in cerebral ischemia |
| Q48510916 | Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. |
| Q48938399 | Oligodendroglial cell death with DNA fragmentation in the white matter under chronic cerebral hypoperfusion: comparison between normotensive and spontaneously hypertensive rats. |
| Q71879401 | Oligodendroglial development in human fetal cerebrum |
| Q37607937 | Oligovascular signaling in white matter stroke |
| Q36223227 | Ontogeny and the effects of in utero brain ischemia on interleukin-1β and interleukin-6 protein expression in ovine cerebral cortex and white matter |
| Q64063252 | Osmotic Demyelination: From an Oligodendrocyte to an Astrocyte Perspective |
| Q34510183 | Oxidative glutamate toxicity involves mitochondrial dysfunction and perturbation of intracellular Ca2+ homeostasis |
| Q34494844 | Oxidative stress in schizophrenia: an integrated approach |
| Q36253615 | Oxidative stress kills human primary oligodendrocytes via neutral sphingomyelinase: implications for multiple sclerosis |
| Q27000066 | Parallels between major depressive disorder and Alzheimer's disease: role of oxidative stress and genetic vulnerability |
| Q36941006 | Pathogenesis of cerebral white matter injury of prematurity |
| Q35040275 | Pathogenesis of hypoxic-ischemic cerebral injury in the term infant: current concepts |
| Q27000069 | Pathophysiology and neuroprotection of global and focal perinatal brain injury: lessons from animal models |
| Q30790294 | Pathophysiology of glia in perinatal white matter injury |
| Q48185316 | Periventricular leukomalacia: relation to gestational age and axonal injury |
| Q36508125 | Phosphatidylcholine-specific phospholipase C regulates glutamate-induced nerve cell death. |
| Q40839423 | Posthemorrhagic hydrocephalus and brain injury in the preterm infant: dilemmas in diagnosis and management |
| Q48285622 | Preferential injury of oligodendroblasts by a short hypoxic-ischemic insult |
| Q28077021 | Preterm Hypoxic-Ischemic Encephalopathy |
| Q41202620 | Protandim Protects Oligodendrocytes against an Oxidative Insult |
| Q44316003 | Protection of mature oligodendrocytes by inhibitors of caspases and calpains |
| Q48139879 | Protective effects of resveratrol on glutamate-induced damages in murine brain cultures |
| Q34058564 | RIP1 kinase mediates arachidonic acid-induced oxidative death of oligodendrocyte precursors. |
| Q73338076 | Rapid ischemic cell death in immature oligodendrocytes: a fatal glutamate release feedback loop |
| Q34361149 | Recent advances in human perinatal white matter injury |
| Q28186005 | Recombinant peroxiredoxin 5 protects against excitotoxic brain lesions in newborn mice |
| Q36379914 | Regulation of antioxidant metabolism by translation initiation factor 2alpha |
| Q34080352 | Regulation of glutamate transport in developing rat oligodendrocytes. |
| Q36275021 | Requirement for cGMP in nerve cell death caused by glutathione depletion |
| Q38410871 | Researching glutamate - induced cytotoxicity in different cell lines: a comparative/collective analysis/study |
| Q42159794 | Rifampicin inhibits the toxicity of pre-aggregated amyloid peptides by binding to peptide fibrils and preventing amyloid-cell interaction |
| Q26747485 | Rodent Hypoxia-Ischemia Models for Cerebral Palsy Research: A Systematic Review |
| Q39186874 | Roles of NG2-glia in ischemic stroke |
| Q43906832 | Selective Vulnerability of Subplate Neurons after Early Neonatal Hypoxia-Ischemia |
| Q36593234 | Subcortical ischemic vascular disease: Roles of oligodendrocyte function in experimental models of subcortical white-matter injury |
| Q35897355 | Synaptic and extrasynaptic neurotransmitter receptors in glial precursors' quest for identity. |
| Q34073426 | System x(c)(-) regulates microglia and macrophage glutamate excitotoxicity in vivo |
| Q26768210 | Systematic Review of Pharmacological Properties of the Oligodendrocyte Lineage |
| Q35569038 | Systemic prenatal insults disrupt telencephalon development: implications for potential interventions |
| Q34279067 | The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities. |
| Q34995998 | The developing oligodendrocyte: key cellular target in brain injury in the premature infant |
| Q37239354 | The impact of myelination on axon sparing and locomotor function recovery in spinal cord injury assessed using diffusion tensor imaging |
| Q36571196 | The pathophysiology of ischemic injury to developing white matter |
| Q36255441 | The regulation of reactive oxygen species production during programmed cell death |
| Q34783988 | The role of glutamate receptor maturation in perinatal seizures and brain injury |
| Q41158837 | The role of monoamine metabolism in oxidative glutamate toxicity. |
| Q36908293 | The role of systemic hemodynamic disturbances in prematurity-related brain injury |
| Q77846814 | The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS |
| Q36523745 | Transplantation of Human Adipose Tissue-Derived Mesenchymal Stem Cells Restores the Neurobehavioral Disorders of Rats With Neonatal Hypoxic-Ischemic Encephalopathy |
| Q37181345 | Tumor necrosis factor alpha mediates lipopolysaccharide-induced microglial toxicity to developing oligodendrocytes when astrocytes are present |
| Q36626214 | Unique biology of gliomas: challenges and opportunities. |
| Q35118717 | Visual function in the brain-damaged child |
| Q42198882 | Vitamin K prevents oxidative cell death by inhibiting activation of 12-lipoxygenase in developing oligodendrocytes |
| Q41453076 | Vulnerability of premyelinating oligodendrocytes to white-matter damage in neonatal brain injury |
| Q33594651 | White matter astrocytes in health and disease |
| Q33589642 | White matter injury in the preterm infant: an important determination of abnormal neurodevelopment outcome |
| Q73302944 | White matter ischaemia |
| Q37983518 | Zinc homeostasis and signaling in glia |
| Q52183788 | [Periventricular leukomalacia. I. Histological and pathophysiological aspects] |
Search more.